Health care system, provider and patient predictors of prescribing quality and efficiency

作者: Yan Tang

DOI:

关键词:

摘要: Understanding factors influencing medication utilization and provider prescribing behavior has important implications for the quality improvement cost containment in health care. This dissertation seeks to shed light on efficiency of prescribing. Chapter one examines association between Medicare Part D plan features choice generic antidepressants, antidiabetics, statins using claims data. Low cost-sharing generics, large differentials vs. brand drugs, tools such as prior authorization step therapy are associated with higher drug use. Modifying benefit design management prescription plans might increase use, which could generate substantial savings program beneficiaries. two physician antipsychotic a Medicaid program. By linking multiple data sources membership modeling approach, we examine degree psychiatrists diversified concentrated their identify concentration Antipsychotic is relatively varies substantially across regularly antipsychotics. Several characteristics treated patient population physicians significantly The few organizations examined have little influence over psychiatrist behavior. three assesses provider-level clozapine polypharmacy practices – strong evidence base other support. Using years’ program, find underuse use non-evidence supported practice non-clozapine polypharmacy. However, these vary tremendously providers. In particular, sizable portion providers more than patients. Quality initiatives may take actions improve evidence-based decrease unsupported public because appropriate can alleviate tremendous economic burdens while inappropriate costs risk undesirable consequences. how make decisions points potential opportunities improving care reducing through altering providers’

参考文章(35)
Julie M. Ganther, David H. Kreling, Consumer perceptions of risk and required cost savings for generic prescription drugs. Journal of the American Pharmaceutical Association. ,vol. 40, pp. 378- 383 ,(2000) , 10.1016/S1086-5802(16)31086-5
Kenneth J. Arrow, Uncertainty and the welfare economics of medical care. 1963. Journal of Health Politics Policy and Law. ,vol. 26, pp. 851- 883 ,(2001) , 10.1215/03616878-26-5-851
James P. Marcin, Zhongmin Li, Richard L. Kravitz, Jian J. Dai, David M. Rocke, Patrick S. Romano, The CABG surgery volume-outcome relationship: temporal trends and selection effects in California, 1998-2004. Health Services Research. ,vol. 43, pp. 174- 192 ,(2007) , 10.1111/J.1475-6773.2007.00740.X
Dana P. Goldman, Geoffrey F. Joyce, Yuhui Zheng, Prescription Drug Cost Sharing JAMA. ,vol. 298, pp. 61- 69 ,(2007) , 10.1001/JAMA.298.1.61
Jane M. Simoni, David Huh, Ira B. Wilson, Jie Shen, Kathy Goggin, Nancy R. Reynolds, Robert H. Remien, Marc I. Rosen, David R. Bangsberg, Honghu Liu, Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study. Journal of Acquired Immune Deficiency Syndromes. ,vol. 60, pp. 466- 472 ,(2012) , 10.1097/QAI.0B013E31825DB0BD
Thomas Rice, Janet Cummings, Reducing the Number of Drug Plans for Seniors: A Proposal and Analysis of Three Case Studies Journal of Health Politics, Policy and Law. ,vol. 35, pp. 961- 997 ,(2010) , 10.1215/03616878-2010-035
Charles E Phelps, Diffusion of information in medical care. Journal of Economic Perspectives. ,vol. 6, pp. 23- 42 ,(1992) , 10.1257/JEP.6.3.23
J. Nielsen, M. Dahm, H. Lublin, D. Taylor, Psychiatrists’ attitude towards and knowledge of clozapine treatment: Journal of Psychopharmacology. ,vol. 24, pp. 965- 971 ,(2010) , 10.1177/0269881108100320
Katharina Hauck, Andrew Street, Performance assessment in the context of multiple objectives: A multivariate multilevel analysis Journal of Health Economics. ,vol. 25, pp. 1029- 1048 ,(2006) , 10.1016/J.JHEALECO.2005.07.009
Gregory Simon, Choosing a First-Line Antidepressant JAMA. ,vol. 286, pp. 3003- 3004 ,(2001) , 10.1001/JAMA.286.23.3003